Skip to main content

Animations

MJFF Publications

2141 - 2150 of 8801 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2024
  • 2024
  • 2024
  • 2023
  • 2025
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Optimizing wrist-worn wearable compliance with insights from two Parkinson’s disease cohort studies
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01016-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: APOE genetic variability in an Egyptian cohort of PD
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2025.1579968
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Peripheral inflammation’s variable impact on cognitive and symptomatic outcomes in Parkinson’s disease: a longitudinal and cross-sectional analysis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01019-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Towards early diagnosis and screening of Alzheimer’s disease using frequency locked whispering gallery mode microtoroids
    Journal Name: npj Biosensing
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s44328-024-00009-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.086490
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub‐haplotypes
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.086923
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Multi‐cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.077212
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Comparative mapping of single‐cell transcriptomic landscapes in neurodegenerative diseases
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.70012
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Characterizing the expression profile of 3R tau pathology in Pick’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adt6105
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13893
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.